Table 3 Throughput times and hospital visits, pre- and post-MFDC
| Â | Pre | Post | Significance | |||
|---|---|---|---|---|---|---|
2007 (n = 21) | 2008 (n = 20) | 2010 (n = 24) | 2013 (n = 24) | p ANOVA | pair wise comparison | |
Throughput time (days) | ||||||
| Â | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Â | Â |
 Access first consultation | 6.0 (7.5*) | 5.9 (3.9) | 4.9 (3.5) | 7.7 (8.0) | .592 | – |
 Diagnostic procedures | 20.6 (10.6) | 11.4 (7.4) | 8.7 (5.6) | 13.0 (8.0) | <.000 | 2007–2008: .013; 2007–2010: .000; 2007–2013: .049 |
 Start first treatment | 32.6 (13.8) | 22.2 (9.2*) | 23.7 (8.4) | 29.3 (11.3) | .009 | 2007–2008: .038 |
Number hospital visits | ||||||
 Diagnostic procedures | 3.0 (1.7) | 2.2 (0.7*) | 1.7 (0.7) | 3.0 (1.3) | <.000 | 2007–2010: .014; 2008–2013: .049; 2010–2013: .001 |
 Diagnosis to start Treatment | 2.1 (1.5) | 1.4 (0.9*) | 2.4 (1.9) | 3.1 (2.2) | .032 | 2008–2013: .012 |
 Total | 5.1 (1.7) | 3.6 (1.0*) | 4.1 (2.1) | 6.0 (2.3) | <.000 | 2007–2008: .006; 2008–2013: .000; 2010–2013: .021 |
Start treatment within 30 days | 52% | 83% | 71% | 54% | .132 | 2007–2008: .040 |